DST studies in psychotic depression: A meta-analysis

American Journal of Psychiatry

Volumn 154, Issue 11, 1997, Pages 1497-1503

  Craig Nelson, J ^a,c   Davis, John M ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ARTICLE; CLINICAL TRIAL; DEPRESSION; DOPAMINE RELEASE; HUMAN; HYDROCORTISONE RELEASE; HYPERCORTISOLISM; MANIC DEPRESSIVE PSYCHOSIS; MELANCHOLIA; META ANALYSIS; PRIORITY JOURNAL;

EID: 1842288547     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.154.11.1497     Document Type: Article

References (82)

1. Charney DS, Nelson JC: Delusional and nondelusional unipolar depression: further evidence for distinct subtypes. Am J Psychiatry 1981; 138:328-333
2. Lykouras E, Christodoulou GN, Malliaras D: Type and content of delusions in unipolar psychotic depression. J Affect Disord 1985; 9:249-252
3. Coryell W, Endicott J, Keller M, Andreasen NC: Phenomenology and family history in DSM-III psychotic depression. J Affect Disord 1985; 9:13-18
4. Miller F, Chabrier LA: Delusional and nondelusional unipolar depression: further evidence for distinct subtypes. Hosp Community Psychiatry 1986; 37:1157-1158
5. Kettering RL, Harrow M, Grossman L, Meltzer HY: The prognostic relevance of delusions in depression: a follow-up study. Am J Psychiatry 1987; 144:1154-1160
6. Baldwin RC: Delusional and nondelusional depression in late life: evidence for distinct subtypes. Br J Psychiatry 1988; 152:39-44
7. Maj M, Pirozzi R, DeCaprio EL: Major depression with mood-congruent psychotic features: a distinct diagnostic entity or a more severe subtype of depression? Acta Psychiatr Scand 1990; 82:439-444
8. Leckman JF, Weissman MM, Prusoff BA: Subtypes of depression. Arch Gen Psychiatry 1984; 41:833-838
9. Endicott J, Nee J, Coryell W, Keller M, Andreasen N, Croughan J: Schizoaffective, psychotic, and nonpsychotic depression: differential familial association. Compr Psychiatry 1986; 27:1-13
10. Chan CH, Janicak PG, Davis JM: Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. J Clin Psychiatry 1987; 48:197-200
11. Schatzberg AF, Rothschild AJ: Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? Am J Psychiatry 1992; 149:733-745
12. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James NM, Kronfol Z, Lohr N, Steiner M, de Vigne JP, Young E: A specific laboratory test for the diagnosis of melancholia: standardization, validation, and clinical utility. Arch Gen Psychiatry 1981; 38:15-22
13. Spitzer RL, Endicott J, Robins E: Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders, 3rd ed. New York, New York State Psychiatric Institute, Biometrics Research, 1977
14. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22:719-748
15. Emerson JD: Combining estimates of the odds ratio: the state of the art. Stat Methods Med Res 1994; 3:157-178
16. APA Task Force on Laboratory Tests in Psychiatry: The dexamethasone suppression test: an overview of its current status in psychiatry. Am J Psychiatry 1987; 144:1253-1262
17. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188
18. Mendlewicz J, Charles G, Franckson JM: The dexamethasone suppression test in affective disorder: relationship to clinical and genetic subgroups. Br J Psychiatry 1982; 141:464-470
19. Coryell W, Gaffney G, Burkhardt PE: The dexamethasone suppression test and familial subtypes of depression - a naturalistic replication. Biol Psychiatry 1982; 17:33-40
20. Asnis GM, Halbreich U, Nathan RS, Ostrow L, Novacenko H, Endicott J, Sachar EJ: The dexamethasone suppression test in depressive illness: clinical correlates. Psychoneuroendocrinology 1982; 7:295-301
21. Rudorfer MV, Hwu HG, Clayton PJ: Dexamethasone suppression testing in primary depression: significance of family history and psychosis. Biol Psychiatry 1982; 17:41-48
22. Schatzberg AF, Rothschild AJ, Stahl JB, Bond TC, Rosenbaum AH, Lofgren SB, MacLaughlin RA, Sullivan MA, Cole JO: The dexamethasone suppression test: identification of subtypes of depression. Am J Psychiatry 1983; 140:88-91
23. Caroff S, Winokur A, Rieger W, Schweizer E, Amsterdam J: Response to dexamethasone in psychotic depression. Psychiatry Res 1983; 8:59-64
24. Coryell W, Pfohl B, Zimmerman M: The clinical and neuroendocrine features of psychotic depression. J Nerv Ment Dis 1984; 172:521-528
25. Nelson WH, Khan A, Orr WW Jr: Delusional depression: phenomenology, neuroendocrine function, and tricyclic antidepressant response. J Affect Disord 1984; 6:297-306
26. Rihmer Z, Arato M, Szadoczyk E, Revai K, Demeter E, Gyorgy S, Udvarhelyi P: The dexamethasone suppression test in psychotic versus nonpsychotic endogenous depression. Br J Psychiatry 1984; 145:508-511
27. Ayuso-Gutierrez JL, Almoguera MI, Garcia-Camba E, Frias JO, Cabranes JA: The dexamethasone suppression test in delusional depression: further findings. J Affect Disord 1985; 8:147-151
28. Evans DL, Nemeroff CB: The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis. J Psychiatr Res 1987; 21:185-194
29. Levy AB, Stern SL: DST and TRH stimulation test in mood disorder subtypes. Am J Psychiatry 1987; 144:472-475
30. Rothschild AJ, Schatzberg AF, Langlais PJ, Lerbinger JE, Miller MM, Cole JO: Psychotic and nonpsychotic depressions, I: comparison of plasma catecholamines and cortisol measures. Psychiatry Res 1987; 20:143-153
31. Brown RP, Stoll PM, Stokes PE, Frances A, Sweeney J, Kocsis JH, Mann JJ: Adrenocortical hyperactivity in depression: effects of agitation, delusions, melancholia, and other illness variables. Psychiatry Res 1987; 23:167-178
32. Feighner JP, Robins E, Guze SB, Woodruff RA Jr, Winokur G, Munoz R: Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972; 26:57-63
33. Carroll BJ, Curtis GC, Mendels J: Neuroendocrine regulation in depression: discrimination of depressed from nondepressed patients. Arch Gen Psychiatry 1976; 33:1051-1058
34. Brown WA, Shuey I: Response to dexamethasone and subtype of depression. Arch Gen Psychiatry 1980; 37:747-751
35. Carroll BJ, Feinberg M, Greden JF, Haskett RF, James MN, Steiner M, Tarika J: Diagnosis of endogenous depression: comparison of clinical, research and neuroendocrine criteria. J Affect Disord 1980; 2:177-194
36. Berger M, Doerr P, Lund R, Bronisch T, vonZerssen D: Neuroendocrinological and neurophysiological studies in major depressive disorders: are there biological markers for the endogenous subtype? Biol Psychiatry 1982; 17:1217-1242
37. Coryell W, Gaffney G, Burkhardt PE: DSM-III melancholia and the primary-secondary distinction: a comparison of concurrent validity by means of the dexamethasone suppression test. Am J Psychiatry 1982; 139:120-122
38. Giles DE, Rush AJ: Relationship of dysfunctional attitudes and dexamethasone response in endogenous and nonendogenous depression. Biol Psychiatry 1982; 17:1303-1314
39. Meltzer HY, Fang VS, Tricou BJ, Robertson A, Piyaka SK: Effect of dexamethasone on plasma prolactin and cortisol levels in psychiatric patients. Am J Psychiatry 1982; 136:763-768
40. Arana GW, Barreira PJ, Cohen BM, Lipinski JF, Fogelson D: The dexamethasone suppression test in psychotic disorders. Am J Psychiatry 1983; 140:1521-1523
41. Evans DL, Burnett GB, Nemeroff CB: The dexamethasone suppression test in the clinical setting. Am J Psychiatry 1983; 140: 586-589
42. Grosser BI, Brainard J, Byerley B, Reimherr F, Wood D: Low sensitivity of the dexamethasone suppression test in melancholia, in 1983 Annual Meeting New Research Program and Abstracts. Washington, DC, American Psychiatric Association, 1983, p NR21
43. Jaffe K, Barnshaw HD, Kennedy ME: The dexamethasone suppression test in depressed outpatients with and without melancholia. Am J Psychiatry 1983; 140:492-493
44. Peselow ED, Goldring N, Fieve RR, Wright R: The dexamethasone suppression test in depressed outpatients and normal control subjects. Am J Psychiatry 1983; 140:245-247
45. Nasr SJ, Pandey G, Altman EG, Gibbons R, Gaviria FM, Davis JM: Symptom profile of patients with positive DST: a pilot study. Biol Psychiatry 1983; 18:571-574
46. Rabkin JG, Quitkin FM, Stewart JW, McGrath PJ, Puig-Antich J: The dexamethasone suppression test with mildly to moderately depressed outpatients. Am J Psychiatry 1983; 140:926-927
47. Caine ED, Yerevanian BI, Bamford KA: Cognitive function and the dexamethasone suppression test in depression. Am J Psychiatry 1984; 141:116-118
48. Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E: Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups: a multicenter study. Arch Gen Psychiatry 1984; 41:257-267
49. Zimmerman M, Coryell W, Pfohl B, Stangl D: Four definitions of endogenous depression and the dexamethasone suppression test. J Affect Disord 1985; 8:37-45
50. Roy A: Cortisol nonsuppression in depression: relationship to clinical variables. J Affect Disord 1988; 14:265-270
51. Miller KB, Nelson JC: Does the dexamethasone suppression test relate to subtypes, factors, symptoms, or severity? Arch Gen Psychiatry 1987; 44:769-774
52. Nelson JC, Mazure CM, Jatlow PI: Does melancholia predict response in major depression? J Affect Disord 1990; 18:157-165
53. Schatzberg AF, Rothschild AJ, Langlais PJ, Bird ED, Cole JO: A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatr Res 1985; 19:57-64
54. Schatzberg AF, Rothschild AJ: The roles of glucocorticoid and dopaminergic systems in delusional (psychotic) depression. Ann NY Acad Sci 1988; 537:462-471
55. Rothschild AJ, Schatzberg AF, Rosenbaum AH, Stahl JB, Cole JO: The dexamethasone suppression rest as a discriminator among subtypes of psychotic patients. Br J Psychiatry 1982; 141: 471-474
56. Klein HE, Bender W, Mayr H, Niederschweiberer A, Schmauss M: The DST and its relationship to psychiatric diagnosis, symptoms and treatment outcome. Br J Psychiatry 1984; 145:591-599
57. Kasper S, Beckmann H: Dexamethasone suppression test in a pluridiagnostic approach: its relationship to psychopathological and clinical variables. Acta Psychiatr Scand 1983; 68:31-37
58. Zimmerman M, Coryell W, Pfohl B: The validity of the dexamethasone suppression test as a marker for endogenous depression. Arch Gen Psychiatry 1986; 43:347-355
59. Zimmerman M, Stangl D, Coryell W: The Research Diagnostic Criteria for endogenous depression and the dexamethasone suppression test: a discriminant function analysis. Psychiatry Res 1985; 14:197-208
60. Nasr SJ, Gibbons RD: Depressive symptoms associated with dexamethasone resistance. Psychiatry Res 1983; 10:183-189
61. Brown WA, Qualls CB: Pituitary-adrenal disinhibition in depression: marker of a subtype with characteristic clinical features and response to treatment? Psychiatry Res 1981; 4:115-128
62. Alessi NE, Robbins DR: Symptoms and subtypes of depression among adolescents distinguished by the dexamethasone suppression test: a preliminary report. Psychiatry Res 1984; 11:177-184
63. Reus VI: Pituitary-adrenal disinhibition as the independent variable in the assessment of behavioral symptoms. Biol Psychiatry 1982; 17:317-326
64. Rubin AL, Price LH, Charney DS, Heninger GR: Noradrenergic function and the cortisol response to dexamethasone in depression. Psychiatry Res 1985; 15:5-15
65. Krishnan KRR, France RD, Pelson S, McCann UD, Manepalli AN, Davidson JRT: What does the dexamethasone suppression test identify? Biol Psychiatry 1985; 20:957-964
66. Arana GW, Baldessarini RJ, Ornsteen M: The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Arch Gen Psychiatry 1985; 42:1193-1204
67. Garvey MJ, Schaffer C, Schaffer L, Perry P: Is DST status associated with depression characteristics? J Affect Disord 1989; 16: 159-165
68. Rosenthal R: The file drawer problem and tolerance for null results. Psychol Bull 1979; 86:638-641
69. Janicak PG, Pandey GN, Davis JM, Boshes R, Bresnahan D, Sharma R: Response of psychotic and nonpsychotic depression to phenelzine. Am J Psychiatry 1988; 145:93-95
70. Nelson JC, Mazure CM, Jatlow PI: Characteristics of desipramine-refractory depression. J Clin Psychiatry 1994; 55:12-19
71. Roose SP, Glassman AH, Walsh BT, Woodring S, Vital-Herne J: Depression, delusions, and suicide. Am J Psychiatry 1983; 140: 1159-1162
72. Rothschild AJ, Langlais PJ, Schatzberg AF, Walsh FX, Cole JO, Bird ED: Dexamethasone increases plasma free dopamine in man. J Psychiatr Res 1984; 18:217-223
73. Wolkowitz OM, Doran A, Breier A, Roy A, Jimerson DC, Sutton ME, Golden RN, Paul SM, Pickar D: The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol. Arch Gen Psychiatry 1987; 44:782-789
74. Wolkowitz OM, Doran A, Breier A, Roy A, Pickar D: Specificity of plasma HVA response to dexamethasone in psychotic depression. Psychiatry Res 1989; 29:177-186
75. Sweeney D, Nelson JC, Bowers MB, Maas J, Heninger G: Delusional versus non-delusional depression: neurochemical differences (letter). Lancet 1978; 2:100-101
76. Aberg-Wistedt A, Wistedt B, Bertilsson L: Higher CSF levels of HVA and 5-HIAA in delusional compared to nondelusional depression (letter). Arch Gen Psychiatry 1985; 42:925-926
77. Agren H, Terenius L: Hallucinations in patients with major depression: interactions between CSF monoaminergic and endorphinergic indices. J Affect Disord 1985; 9:25-34
78. Brown RP: CSF monoamine and depressive subtypes, in 1987 Annual Meeting New Research Program and Abstracts. Washington, DC, American Psychiatric Association, 1987, p 28
79. Devanand DP, Bowers MB, Hoffman FJ, Nelson JC: Elevated plasma homovanillic acid in depressed females with melancholia and psychosis. Psychiatry Res 1985; 15:1-4
80. Mazure CM, Bowers MB, Hoffman F, Miller KB, Nelson JC: Plasma catecholamine metabolites in subtypes of major depression. Biol Psychiatry 1987; 22:1469-1472
81. Bowers MB: Cerebrospinal fluid 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) following probenecid in unipolar depressives treated with amitriptyline. Psychopharmacology (Berl) 1972; 23:26-33
82. Linnoila M, Karoum F, Potter WZ: Effects of antidepressant treatments on dopamine turnover in depressed patients. Arch Gen Psychiatry 1983; 40:1015-1017